Skip to Main Content

Paper Details

Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review.
Clin Pharmacokinet
11
2022
Author NameAffiliation
Sharon R LewinRoyal Melbourne Hospital
Sharon R LewinThe University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Sharon R LewinAlfred Hospital and Monash University
Balasubramanian Venkateshand Wesley Hospital, The University of Queensland
Balasubramanian VenkateshThe George Institute for Global Health
  • 1 - 5

Datasets

Release 1.2